Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review Article
  • Published:

Is bowel preparation before colonoscopy a risky business for the kidney?

Abstract

Acute phosphate nephropathy after bowel preparation with oral sodium phosphate (OSP) for colonoscopy has emerged as an important clinical entity. In 2004, five cases of nephrocalcinosis and irreversible renal failure after bowel preparation with OSP were reported. More recently, several retrospective studies have shown that the incidence of acute kidney injury after OSP use is in the range of 1–4%, similar to the incidence of contrast nephropathy in the general population. The degree of renal failure is not generally as severe as in the first reported cases, but irreversible damage can still occur. Millions of people worldwide undergo screening colonoscopies for colon and rectal cancer after the age of 50, so careful patient selection and monitoring for possible complications is essential when OSP is used. In addition to educating patients about the possibility of renal damage, physicians should routinely watch for considerable weight loss during bowel preparation and correct the fluid deficit as needed. Carrying out a renal function panel, which includes serum phosphorus level, is prudent after colonoscopy. Alternative bowel cleansing agents are needed because calcium phosphate precipitation is inevitable after OSP use even in the normal kidney.

Key Points

  • Acute phosphate nephropathy (APN) can be diagnosed days or months after bowel preparation with oral sodium phosphate (OSP) before colonoscopy; specific symptoms or signs might not be present

  • Epidemiological studies reveal that APN occurs in 1–4% of patients with normal or near-normal renal function

  • The development of APN is directly related to the phosphate load imposed by OSP, which leads to production of calcium phosphate crystals and damage of renal epithelial cells

  • OSP also causes electrolyte abnormalities, including hyperphosphatemia, hypocalcemia, hypokalemia, hypernatremia, and hyponatremia

  • The standard OSP regimen should be modified by reducing, delaying or replacing the second dose with another bowel cleansing agent, to reduce toxicity

  • If OSP is used, the colonoscopy center should consider performing serum biochemistry tests after the procedure, in order to detect any renal or electrolyte abnormalities

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Time course of changes in serum and urinary phosphorus and calcium concentrations after standard doses of oral sodium phosphate.

Similar content being viewed by others

References

  1. Wexner SD et al. (2006) A consensus document on bowel preparation before colonoscopy: prepared by a task force from the American Society of Colon and Rectal Surgeons (ASCRS), the American Society for Gastrointestinal Endoscopy (ASGE), and the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES). Surg Endosc 20: 1147–1160

    Article  Google Scholar 

  2. Hookey LC et al. (2002) The safety profile of oral sodium phosphate for colonic cleansing before colonoscopy in adults. Gastrointest Endosc 56: 895–902

    Article  Google Scholar 

  3. Markowitz GS et al. (2004) Renal failure due to acute nephrocalcinosis following oral sodium phosphate bowel cleansing. Hum Pathol 35: 675–684

    Article  Google Scholar 

  4. Desmeules S et al. (2003) Acute phosphate nephropathy and renal failure. N Engl J Med 349: 1006–1007

    Article  CAS  Google Scholar 

  5. Gonlusen G et al. (2006) Renal failure and nephrocalcinosis associated with oral sodium phosphate bowel cleansing: clinical patterns and renal biopsy findings. Arch Pathol Lab Med 130: 101–106

    PubMed  Google Scholar 

  6. Aasebø W et al. (2007) Kidney biopsies taken before and after oral sodium phosphate bowel cleansing. Nephrol Dial Transplant 22: 920–922

    Article  Google Scholar 

  7. Markowitz GS et al. (2005) Renal failure following bowel cleansing with a sodium phosphate purgative. Nephrol Dial Transplant 20: 850–851

    Article  Google Scholar 

  8. Tan HL et al. (2002) Severe hyperphosphataemia and associated electrolyte and metabolic derangement following the administration of sodium phosphate for bowel preparation. Anaesthesia 57: 478–483

    Article  CAS  Google Scholar 

  9. Ahmed M et al. (1996) Oral sodium phosphate catharsis and acute renal failure. Am J Gastroenterol 91: 1261–1262

    CAS  PubMed  Google Scholar 

  10. Beyea A et al. (2007) Acute phosphate nephropathy following oral sodium phosphate solution to cleanse the bowel for colonoscopy. Am J Kidney Dis 50: 151–154

    Article  Google Scholar 

  11. Ma RC et al. (2007) Acute renal failure following oral sodium phosphate bowel preparation in diabetes. Diabetes Care 30: 182–183

    Article  Google Scholar 

  12. Raskin P et al. (1978) The hypercalciuria of diabetes mellitus: its amelioration with insulin. Clin Endocrinol (Oxf) 9: 329–335

    Article  CAS  Google Scholar 

  13. Hurst FP et al. (2007) Association of oral sodium phosphate purgative use with acute kidney injury. J Am Soc Nephrol 18: 3192–3198

    Article  CAS  Google Scholar 

  14. Brunelli SM et al. (2007) Risk of kidney injury following oral phosphosoda bowel preparations. J Am Soc Nephrol 18: 3199–2205

    Article  Google Scholar 

  15. Singal AK et al. (2008) The renal safety of bowel preparations for colonoscopy: a comparative study of oral sodium phosphate solution and polyethylene glycol. Aliment Pharmacol Ther 27: 41–47

    Article  CAS  Google Scholar 

  16. Russmann S et al. (2007) Risk of impaired renal function after colonoscopy: a cohort study in patients receiving either oral sodium phosphate or polyethylene glycol. Am J Gastroenterol 102: 2655–2663

    Article  Google Scholar 

  17. Khurana A et al. (2008) The effect of oral sodium phosphate drug products on renal function in adults undergoing bowel endoscopy. Arch Intern Med 168: 593–597

    Article  CAS  Google Scholar 

  18. Harkonen S and Kjellstrand C (1981) Contrast nephropathy. Am J Nephrol 1: 69–77

    Article  CAS  Google Scholar 

  19. Tan JJ and Tjandra JJ (2006) Which is the optimal bowel preparation for colonoscopy—a meta-analysis. Colorectal Dis 8: 247–258

    Article  CAS  Google Scholar 

  20. Beloosesky Y et al. (2003) Electrolyte disorders following oral sodium phosphate administration for bowel cleansing in elderly patients. Arch Intern Med 163: 803–808

    Article  Google Scholar 

  21. Fass R et al. (1993) Fatal hyperphosphatemia following Fleet Phospo-Soda in a patient with colonic ileus. Am J Gastroenterol 88: 929–932

    CAS  PubMed  Google Scholar 

  22. Fine A and Patterson J (1997) Severe hyperphosphatemia following phosphate administration for bowel preparation in patients with renal failure: two cases and a review of the literature. Am J Kidney Dis 29: 103–105

    Article  CAS  Google Scholar 

  23. Niemeijer ND et al. (2008) Symptomatic hypocalcemia after sodium phosphate preparation in an adult with asymptomatic hypoparathyroidism. Eur J Gastroenterol Hepatol 20: 356–358

    Article  Google Scholar 

  24. Vanner SJ et al. (1990) A randomized prospective trial comparing oral sodium phosphate with standard polyethylene glycol-based lavage solution (Golytely) in the preparation of patients for colonoscopy. Am J Gastroenterol 85: 422–427

    CAS  PubMed  Google Scholar 

  25. DiPalma JA et al. (1996) Biochemical effects of oral sodium phosphate. Dig Dis Sci 41: 749–753

    Article  CAS  Google Scholar 

  26. Caswell M et al. (2007) The time course and effect on serum electrolytes of oral sodium phosphates solution in healthy male and female volunteers. Can J Clin Pharmacol 14: e260–e274

    PubMed  Google Scholar 

  27. Clarkston WK et al. (1996) Oral sodium phosphate versus sulfate-free polyethylene glycol electrolyte lavage solution in outpatient preparation for colonoscopy: a prospective comparison. Gastrointest Endosc 43: 42–48

    Article  CAS  Google Scholar 

  28. Frizelle FA and Colls BM (2005) Hyponatremia and seizures after bowel preparation: report of three cases. Dis Colon Rectum 48: 393–396

    Article  CAS  Google Scholar 

  29. Portale AA et al. (1996) Effect of aging on the metabolism of phosphorus and 1,25-dihydroxyvitamin D in healthy men. Am J Physiol 270: E483–E490

    CAS  PubMed  Google Scholar 

  30. Ito N et al. (2007) Effect of acute changes of serum phosphate on fibroblast growth factor (FGF)23 levels in humans. J Bone Miner Metab 25: 419–422

    Article  CAS  Google Scholar 

  31. Patel V et al. (2007) Pathogenesis of nephrocalcinosis after sodium phosphate catharsis to prepare for colonoscopy: intestinal phosphate absorption and its effect on urine mineral and electrolyte excretion. Hum Pathol 38: 193–194

    Article  CAS  Google Scholar 

  32. Asplin JR et al. (1996) Evidence of calcium phosphate supersaturation in the loop of Henle. Am J Physiol 270: F604–F613

    CAS  PubMed  Google Scholar 

  33. Aihara K et al. (2003) Calcium phosphate-induced renal epithelial injury and stone formation: involvement of reactive oxygen species. Kidney Int 64: 1283–1291

    Article  CAS  Google Scholar 

  34. Umekawa T et al. (2003) Increased expression of monocyte chemoattractant protein-1 (MCP-1) by renal epithelial cells in culture on exposure to calcium oxalate, phosphate and uric acid crystals. Nephrol Dial Transplant 18: 664–669

    Article  CAS  Google Scholar 

  35. Rex DK (2007) Dosing considerations in the use of sodium phosphate bowel preparations for colonoscopy. Ann Pharmacother 41: 1466–1475

    Article  CAS  Google Scholar 

  36. Rostom A et al. (2006) A randomized prospective trial comparing different regimens of oral sodium phosphate and polyethylene glycol-based lavage solution in the preparation of patients for colonoscopy. Gastrointest Endosc 64: 544–552

    Article  Google Scholar 

  37. Barclay RL et al. (2002) Carbohydrate-electrolyte rehydration protects against intravascular volume contraction during colonic cleansing with orally administered sodium phosphate. Gastrointest Endosc 56: 633–638

    Article  Google Scholar 

  38. Tjandra JJ and Tagkalidis P (2004) Carbohydrate-electrolyte (E-Lyte) solution enhances bowel preparation with oral fleet phospho-soda. Dis Colon Rectum 47: 1181–1186

    Article  Google Scholar 

Download references

Acknowledgements

Charles P Vega, University of California, Irvine, CA, is the author of and is solely responsible for the content of the learning objectives, questions and answers of the Medscape-accredited continuing medical education activity associated with this article.

Author information

Authors and Affiliations

Authors

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lien, YH. Is bowel preparation before colonoscopy a risky business for the kidney?. Nat Rev Nephrol 4, 606–614 (2008). https://doi.org/10.1038/ncpneph0939

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpneph0939

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing